- Home
- SGHT vs CIK Comparison
SGHT vs CIK Comparison
Compare SGHT & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- CIK
- Stock Information
- Founded
- SGHT 2011
- CIK 1987
- Country
- SGHT United States
- CIK United States
- Employees
- SGHT N/A
- CIK N/A
- Industry
- SGHT Medical Specialities
- CIK Finance/Investors Services
- Sector
- SGHT Health Care
- CIK Finance
- Exchange
- SGHT Nasdaq
- CIK Nasdaq
- Market Cap
- SGHT 140.1M
- CIK 156.6M
- IPO Year
- SGHT 2021
- CIK N/A
- Fundamental
- Price
- SGHT $3.03
- CIK $2.83
- Analyst Decision
- SGHT Buy
- CIK
- Analyst Count
- SGHT 7
- CIK 0
- Target Price
- SGHT $3.92
- CIK N/A
- AVG Volume (30 Days)
- SGHT 161.2K
- CIK 115.4K
- Earning Date
- SGHT 05-08-2025
- CIK 01-01-0001
- Dividend Yield
- SGHT N/A
- CIK 9.03%
- EPS Growth
- SGHT N/A
- CIK N/A
- EPS
- SGHT N/A
- CIK N/A
- Revenue
- SGHT $78,109,000.00
- CIK N/A
- Revenue This Year
- SGHT N/A
- CIK N/A
- Revenue Next Year
- SGHT $11.17
- CIK N/A
- P/E Ratio
- SGHT N/A
- CIK N/A
- Revenue Growth
- SGHT N/A
- CIK N/A
- 52 Week Low
- SGHT $2.03
- CIK $2.50
- 52 Week High
- SGHT $8.45
- CIK $3.19
- Technical
- Relative Strength Index (RSI)
- SGHT 56.13
- CIK 53.58
- Support Level
- SGHT $2.81
- CIK $2.81
- Resistance Level
- SGHT $3.26
- CIK $2.83
- Average True Range (ATR)
- SGHT 0.24
- CIK 0.03
- MACD
- SGHT -0.01
- CIK 0.01
- Stochastic Oscillator
- SGHT 38.57
- CIK 83.33
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations, and individuals.